# Immuneering Corp: Form 8-K, filed May 23, 2024

- Company: [Immuneering Corp](/companies/imrx.md) (CIK 1790340)
- Form: 8-K
- Filed: 2024-05-23
- Accepted by EDGAR: May 23, 2024, 16:10 ET
- Period: 2024-05-21
- Accession: 0001790340-24-000058
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1790340/000179034024000058/imrx-20240521.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1790340/000179034024000058/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1790340/000179034024000058/imrx-20240521.htm

Filed May 23, 2024.
Source: SEC EDGAR, the filing index for accession 0001790340-24-000058. Last ingested by Listed: Nov 10, 2026, 03:06 ET. No prices; not investment advice.